首页 | 本学科首页   官方微博 | 高级检索  
     


Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial
Authors:Victor A. Macias  Inmaculada Barrera-Mellado
Affiliation:1. Radiation Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain;2. Statistics Department, University of Salamanca, Salamanca, Spain
Abstract:
Keywords:stereotactic body radiotherapy  brachytherapy  high risk  hypofractionated radiotherapy  quality of life  #ProstateCancer  #PCSM
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号